MARK FURLONG

Profile

First Name

: MARK

Middle Name

:

Last Name

: FURLONG

Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-12-18 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-12-18 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-12-18 
D
OTHER HEALTH CARE 
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835] 
OVER $100,000,000 
Equity 
2020-03-30 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2019-12-18 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
 
2018-02-01